Fifty years of hairy cell leukemia treatments

Leukemia and Lymphoma

Volumn 52, Issue SUPPL. 2, 2011, Pages 3-5

  Golomb, Harvey M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

cladribine; hairy cell leukemia; pentostatin; rituximab

Indexed keywords

ALPHA INTERFERON; CHLORAMBUCIL; CLADRIBINE; IMMUNOTOXIN; IMMUNOTOXIN BL 22; PENTOSTATIN; RITUXIMAB; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; ERYTHROCYTE COUNT; HAIRY CELL LEUKEMIA; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; SPLENECTOMY; SPLENOMEGALY; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT FAILURE; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CLADRIBINE; HUMANS; LEUKEMIA, HAIRY CELL; PENTOSTATIN; TREATMENT OUTCOME;

EID: 79957505312     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.565094     Document Type: Article

References (18)

1. Golomb, HM, Catovsky D, Golde, DW. Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med 1978;89:677-683. (Pubitemid 9016593)
2. Golomb HM, Vardiman JW. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood 1983;61:349-352. (Pubitemid 13137656)
3. Quesada JR, Reubin J, Manning JT, et al. a-Interferon for induction of remission in hairy cell leukemia. N Engl J Med 1984;310:15-18. (Pubitemid 14212475)
4. Golomb HM, Vardiman JW. Hairy cell leukemia. In: Holland J, Frei E, editors. Cancer Medicine. Hamilton, ON: BC Decker; 2003. Ch. 131.
5. Spiers ASD, Parekh SJ, Beshop MB. Hairy cell leukemia: induction of complete remission with pentostatin. J Clin Oncol 1984;2:1336-1342. (Pubitemid 15179534)
6. Grever M, Kopecky K, Foucar MK, et al. Randomized comparsion of pentostatin versus interferon a- 2a in previously untreated patients with hairy cell leukemia; an intergroup study. J Clin Oncol 1995;13:974-982.
7. Piro L, Carrera CJ, Carson DA, et al. Lasting remissions in hairy cell leukemia induced by a single infusion of 2' chlorodeoxyadenosine. N Engl J Med 1990;322:1117-1121. (Pubitemid 20149529)
8. Saven A, Buriani C, Koziol JA, et al. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998;92:1918-1926. (Pubitemid 28446680)
9. Mhawech-Fauceglia P, Oberholzer M, Aschenafi S, et al. Potential predictive patterns of minimal residual disease detected by immunohistochemistry on bone marrow biopsy specimens during long-term follow-up in patients treated with cladribine for hairy cell leukemia. Arch Pathol Lab Med 2006;130:374-377.
10. Sigal DS, Sharpe R, Burian C, et al. Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine. Blood 2010;115:1893-1896.
11. Ravandi F, Jorgensen JL, O'Brien SM, et al. Eradication of minimal residual disease in hairy cell leukemia. Blood 2006;107:4658-4662. (Pubitemid 43882611)
12. Pileri S, Sabattini E, Poggi S, et al. Bone marrow biopsy in hairy cell leukemia (HCL) patients, histological and immunohistological analysis of 46 cases treated with different therapies. Leuk Lymphoma 1994;14(suppl 1):67-71. (Pubitemid 24282596)
13. Konwalinka G, Schirmer M, Hilbe W, et al. Minimal residual disease in hairy cell leukemia after treatment with 2'chlorodeoxyadenosine. Blood Cells Mol Dis 1995;21:142-151.
14. Spielberger RT, Mick R, Ratain MJ, et al. Interferon treatment for hairy cell leukemia: An update on cohort of 69 patients treated from 1983 to 1986. Leuk Lymphoma 1994;14(suppl 1):89-93.
15. Kreitman RJ, Wilson WH, Begeron K, et al. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy resistant hairy cell leukemia. N Engl J Med 2001;345:241-247. (Pubitemid 32695063)
16. Kreitman RJ, Wilson WH, Pastan I. Treatment of hairy cell leukemia: A reply. N Engl J Med 2001;345:1500.
17. Kreitman RJ, Pastan I. BL22 and lymphoid malignancies. Best Pract Res Clin Haematol 2006;19:685-699. (Pubitemid 44418025)
18. Thomas DA, O'Brien S, Bueso-Ramos C, et al. Rituximab in relapsed or refractory hairy cell leukemia. Blood 2003;102:3906-3911. (Pubitemid 37486969)